The Nuclear Research and consultancy Group (NRG) is planning to build the PALLAS reactor in order to replace the High Flux Reactor. This new nuclear reactor will guarantee the production of medical isotopes and the continuation of nuclear research into the future.

The existing High Flux Reactor (in operation since 1961) is reaching the end of its economic life. PALLAS will be equipped to meet the growing world demand for medical isotopes and nuclear knowledge and services more efficiently and effectively.

PALLAS is expected to be built by an international consortium which will also include a representation of Dutch companies. PALLAS will become operational around the year 2018.

The PALLAS reactor has been named after the Greek goddess of wisdom, knowledge and patroness of art and science.